Hostname: page-component-78c5997874-g7gxr Total loading time: 0 Render date: 2024-11-10T18:18:15.554Z Has data issue: false hasContentIssue false

747 – Brain-Derived Neurotrophic Factor and B-Cell Lymphoma Leukemia-2 Plasma Levels in Patients with Subsyndromal Symptomatic Depression

Published online by Cambridge University Press:  15 April 2020

Z. Li
Affiliation:
Department of Neurology, Shanghai Changhai Hospital, Secondary Military Medical University Division of Mood Disorders, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China
Y. Fang
Affiliation:
Division of Mood Disorders, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Objective:

To explore the relationship between brain-derived neurotrophic factor (BDNF) and B-cell lymphoma Leukemia-2 (Bcl-2) plasma levels in subsyndromal symptomatic depression (SSD) patients.

Methods:

In this case-control study, Enzyme-Linked Immunosorbnent Assay (ELISA) method was used to analysed the differences of BDNF plasma levels between SSD group (n=42) and healthy controls (n=51). At the same time Hamilton Depression Rating Scale-17(HAMD17) were assessed the patients'severity.

Result:

There were significant difference of BDNF plasma levels between SSD group (medium 2.97 ng/ml)and healthy group (medium 3.71ng/ml, z=-2.94, P 0.003). Furthermore, BDNF plasma levels in SSD patients were associated with Hamilton score (r -0.53, P < 0.001). Plasma Bcl-2 levels were not different between SSD group (medium 4951 U/ml) and health controls (medium 5574 U/ml) (z = -1.71, P =0.09); and plasma Bcl-2 levels in SSD group were not associated with Hamilton score (r -0.10, P 0.34).

Conclusion:

The study suggested that the decreased BDNF plasma levels were related with the pathophysiology of SSD and it might reflect the severity of disorder.

Type
Abstract
Copyright
Copyright © European Psychiatric Association 2013
Submit a response

Comments

No Comments have been published for this article.